Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target

by Emilio Yángüez, Annika Hunziker, Maria Pamela Dobay, Soner Yildiz, Simon Schading, Elizaveta Elshina, Umut Karakus, Peter Gehrig, Jonas Grossmann, Ronald Dijkman, Mirco Schmolke, Silke Stertz
Published 2018-09-01